Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01465542 · ClinicalTrials.gov registry record
Treatment of APAP Toxicity With IV and Oral NAC 2008-2011
A clinical trial, sponsored by Akron Children's Hospital.
- Completed
- Registry status
- 47
- Enrollment target
NCT01465542: Completed study, sponsored by Akron Children's Hospital.
NCT01465542 is a clinical trial that has completed, run by Akron Children's Hospital. The registered enrollment target is 47 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01465542 has completed, sponsored by Akron Children's Hospital.
- COMPLETED
- Registry status
- 47 participants
- Enrollment target
Study Summary
Retrospective chart review of patients who receive N-acetylcysteine for Acetaminophen(APAP) toxicity to assess length of oral vs. IV treatment and the effect of a Clinical Pharmacology and Toxicology division in the management of APAP ingestions.
Primary Outcome
Length of NAC treatment (in hours) for both IV and PO formulations used in patients with APAP toxicity
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2011-06 |
| Est. Completion | 2011-11 |
What the finished NCT01465542 record still lists
NCT01465542 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 47 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01465542 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01465542 about?
NCT01465542 is a clinical study titled "Treatment of APAP Toxicity With IV and Oral NAC 2008-2011". Retrospective chart review of patients who receive N-acetylcysteine for Acetaminophen(APAP) toxicity to assess length of oral vs. IV treatment and the effect of a Clinical Pharmacology and Toxicology division in the management of APAP ingestions.
What is the current status of trial NCT01465542?
This trial is currently completed. The enrollment target is 47 participants. The study started on 2011-06. Estimated completion is 2011-11.
Who is sponsoring clinical trial NCT01465542?
This trial is sponsored by Akron Children's Hospital, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03313011 · 47 participants
The Neurobiology of Two Distinct Types of Progressive Apraxia of Speech
- NCT03467516 · 47 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma
- NCT03886662 · 47 participants · Phase 1
A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)
- NCT04013802 · 47 participants · Phase 1
TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia